IAPP and type 2 diabetes mellitus: However, overexpression of human IAPP (h-IAPP) in rodent models promotes amyloid deposits, beta-cell dysfunction and apoptosis, consequently leading to reduced beta-cell mass and hyperglycemia [22,33,34], supporting the role of h-IAPP as a contributor to the islet pathology in human T2D.